Junliang Cai
- Co-authors
- Shun LüJifeng FengYuankai ShiYing ChengJianying ZhouAlexander LuftChristine BaudeletLi Zhang
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Lung Cancer Treatments and Mutations (9 papers)Lung Cancer Diagnosis and Treatment (8 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Junliang Cai
12 papers receiving 524 citations
Hit Papers
Peers
Comparison fields: 5 of 42
- Oncology 451
- Pulmonary and Respiratory Medicine 397
- Immunology 65
- Surgery 52
- Cancer Research 52
Countries citing papers authored by Junliang Cai
This map shows the geographic impact of Junliang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junliang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junliang Cai more than expected).
Fields of papers citing papers by Junliang Cai
This network shows the impact of papers produced by Junliang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junliang Cai. The network helps show where Junliang Cai may publish in the future.
Co-authorship network of co-authors of Junliang Cai
This figure shows the co-authorship network connecting the top 25 collaborators of Junliang Cai. A scholar is included among the top collaborators of Junliang Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junliang Cai. Junliang Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 13 | |
| 4 | 6 | |
| 5 | 15 | |
| 6 | 28 | |
| 7 | 90 | |
| 8 | 65 | |
| 9 | 17 | |
| 10 | Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trialbreakdown → | 265 |
| 11 | 1 | |
| 12 | 21 |
About Junliang Cai
Junliang Cai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 12 papers that have together received 534 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Lung Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (451 citations), Pulmonary and Respiratory Medicine (397 citations) and Cancer Research (52 citations). Junliang Cai has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Shun Lü, Jifeng Feng, Yuankai Shi, Ying Cheng, Jianying Zhou, Alexander Luft, Christine Baudelet, Li Zhang, Tony Mok and Caicun Zhou. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.